Recommended Dose of 25% Dextrose for Adult Hypoglycemia
For adult hypoglycemia requiring IV treatment, administer 25 grams of dextrose intravenously, which equals 100 mL of 25% dextrose solution.
Dosing Algorithm
The standard approach for treating adult hypoglycemia depends on the patient's ability to take oral intake:
If Patient Can Take Oral Intake:
- Administer 20 grams of oral glucose (tablets, juice, candy, or other carbohydrates) 1
- Clinical improvement should occur within 15-20 minutes
- Follow with a substantial snack or meal, as the glycemic response is transient (typically less than 2 hours)
If Patient Cannot Take Oral Intake (Altered Mental Status):
- Administer 25 grams of IV dextrose as the standard initial dose 1
- This can be given as:
- 100 mL of 25% dextrose, OR
- 50 mL of 50% dextrose, OR
- 250 mL of 10% dextrose
The FDA label specifies that 10-25 grams of dextrose (20-50 mL of 50% dextrose) is usually adequate for insulin-induced hypoglycemia 2.
Administration Details
Rate of administration: Inject slowly over approximately 1 minute per 5-gram aliquot 3. The maximum safe infusion rate is 0.5 g/kg/hour to avoid glycosuria 2.
Important considerations:
- A subsequent glucose infusion is often needed since the glycemic response to IV glucose is transient 1
- Provide oral food as soon as the patient can safely ingest it
- Repeated doses and supportive treatment may be required in severe cases 2
Evidence Comparison
Recent research demonstrates that 10%, 25%, and 50% dextrose concentrations are equally effective when given in 5-gram aliquots, with no difference in time to achieve normal mental status (median 6 minutes for all three) 3. However, the 10% and 25% groups required lower total median doses (10-15g) compared to 50% dextrose, and fewer patients required the maximum 25-gram dose with lower concentrations 3.
Clinical advantage of 25% over 50% dextrose: Lower concentrations reduce the risk of rebound hyperglycemia, which occurs in 56-73% of patients within 5 minutes of 50% dextrose administration, with mean glucose levels reaching 12.2 mmol/L 4. This rebound hyperglycemia is more pronounced in non-diabetic patients (73.3%) versus diabetic patients (56.3%) 4.
Special Situations
Sulfonylurea overdose: May cause prolonged hypoglycemia requiring hospitalization for extended treatment and observation. Consider octreotide for sulfonylurea-induced hypoglycemia 1.
Diabetic patients: May require additional doses or continuous dextrose-containing fluids if unable to begin oral feeding 4. Six percent of patients required a second 25-gram dose in one study, all of whom were diabetic 4.
Alternative if IV access unavailable: Glucagon 1.0 mg subcutaneous or intramuscular, though this causes substantial transient hyperglycemia and may induce nausea/vomiting 1.